期刊文献+

食管外科手术并发症的定义和分级以及预测 被引量:5

Definition, classification and prediction of complications ;related to esophageal resection
原文传递
导出
摘要 食管切除术是众多食管疾病的主要治疗方式,但也是风险极高的手术之一。因此,降低食管切除术后的病死率与并发症发生率是值得关注的问题,其中对食管外科并发症的定义、分级和预测是食管外科的重要内容。然而,目前尚缺乏对食管外科并发症的统一定义及其严重程度的分级,也无专门针对食管切除术后并发症的预测系统。了解这方面的研究进展对我们预测食管手术的死亡风险、预防并发症的发生及治疗有重要意义。 Esophagectomy is the major treatment for a variety of esophagus diseases. However, despite its wide applications, it is also one of the highest-risk procedures. Thus, reduction of mortality and complication after esophagectomy has drawn much attention, and the definition, classification and prediction of complication following esophagectomy is of vital importance. Unfortunately, there is no unified definition and specific prediction system for complications of esophagectomy until now. We review the&amp'advances in complication research in order to offer references to reduce mortality, prevent or treat complications of this high-risk operation.
作者 陈克能
出处 《中华胃肠外科杂志》 CAS CSCD 北大核心 2015年第9期855-859,共5页 Chinese Journal of Gastrointestinal Surgery
基金 北京市卫生系统高层次卫生技术人才培养计划(2009-2-17) 国家973计划(2011CB504300) 教育部高等学校博士学科点专项科研基金(20130001110108) 国家自然科学基金青年基金(81301748) 教育部“创新团队发展计划”(IRT13003)
关键词 食管切除术 并发症 预防 治疗 Esophagectomy Complications Prevention Treatment
  • 相关文献

参考文献1

二级参考文献69

  • 1Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J Clin 2003; 53:5-26.
  • 2Ruol A, Castoro C, Portale G, Cavallin F, Sileni VC, Cagol M, Alfieri R, Corti L, Boso C, Zaninotto G, Peracchia A, Ancona E. Trends in management and prognosis for esophageal cancer surgery: twenty-five years of experience at a single institution. Arch Surg 2009; 144: 247-254; discussion 254.
  • 3De Vita F, Di Martino N, Orditura M, Cosenza A, Galizia G, Del Genio A, Catalano G. Preoperative chemoradiotherapy for squamous cell carcinoma and adenocarcinoma of the esophagus: a phase U study. Chest 2002; 122:1302-1308.
  • 4Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med 2003; 349:2241-2252.
  • 5Wu PC, Posner MC. The role of surgery in the management of oesophageal cancer. Lancet Onco12003; 4:481-488.
  • 6Jamieson GG, Mathew G, Ludemann R, Wayman J, Myers JC, Devitt PG. Postoperative mortality following oesophagectomy and problems in reporting its rate. Br J Surg 2004; 91:943-947.
  • 7Viklund P, Lindblad M, Lu M, Ye W, Johansson J, Lagergren J. Risk factors for complications after esophageal cancer resection: a prospective population-based study in Sweden. Ann Surg 2006; 243:204-211.
  • 8Gebski V, Burmeister B, Smithers BM, Foo K, Zalcberg J, Simes J. Survival benefits from neoadjuvant chemoradio-therapy or chemotherapy in oesophageal carcinoma: a metaanalysis. Lancet Onco12007; 8:226-234.
  • 9Greer SE, Goodney PP, Sutton JE, Birkmeyer JD. Neoadjuvant chemoradiotherapy for esophageal carcinoma: a meta-analysis. Surgery 2005; 137:172-177.
  • 10Zacherl J, Sendler A, Stein HJ, Ott K, Feith M, Jakesz R, Siewert JR, Fink U. Current status of neoadjuvant therapy for adenocarcinoma of the distal esophagus. World J Surg 2003; 27:1067-1074.

共引文献14

同被引文献29

引证文献5

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部